TGF-β1 is an important pathogenic factor involved in a variety of fibroproliferative disorders, including pulmonary fibrosis [1],[13], and there have been several in vitro reports that showed an increased expression of NO and a subsequent decrease of TGF-β1 due to the increase of NO production [13],[30]. Here, TGFB1 is linked to pulmonary fibrosis.